BioMarin Plans To Reduce Its Global Workforce By Approximately 225 Employees
BioMarin Plans To Reduce Its Global Workforce By Approximately 225 Employees
he Company decided to reduce its workforce in connection with organizational redesign efforts as well as the Company's updated strategy for ROCTAVIAN and its decision to discontinue development of BMN 293, as previously announced by BioMarin on August 5, 2024.
为了ROCTAVIAN的最新策略以及终止BMN293的开发，公司决定在组织重设计划中减少员工数量，正如BioMarin在2024年8月5日公告的那样。
The Company estimates that it will incur aggregate pre-tax charges representing one-time cash expenditures for severance and other employee termination benefits of approximately $30 - $35 million, of which the majority is expected to be incurred during the second half of 2024.
公司估计将产生总计约3000-3500万美元的税前费用，用于一次性现金支出，用于支付离职费和其他员工解雇福利，其中大部分费用预计将在2024年下半年产生。
Impacted employees were notified by August 28, 2024, and workforce reductions are expected to be substantially completed by the end of 2024.
受影响的员工在2024年8月28日前收到通知，裁员工作预计将在2024年年底基本完成。